Company
MedMen Enterprises Inc
CNSX:MMEN
MedMen Enterprises Inc is a cannabis retailer with flagship locations in California, Nevada, Illinois, Florida, and New York. The company offers a robust selection of high-quality products, including MedMen-owned brands LuxLyte and MedMen Red through its premium retail stores, proprietary delivery service, as well as curbside and in-store pick up. MedMen Buds, an industry-first loyalty program, provides exclusive access to promotions, product drops and content. The company believes that a world where cannabis is legal and regulated is safer, healthier and happier.
50 stories
Buds & Duds: Cannabis stocks retreat; MedMen and Sundial lose CEOs
MedMen found its shares in the green but Sundial was not as fortunate
MedMen unveils plans to raise US74mln from offering of class B voting shares, sale of licenses in non-core states
The company said it expects to raise $54 million by selling licences in Arizona and in Illinois
Buds & Duds: Cannabis stocks higher on Thursday as troubled retailer MedMen reveals new round of layoffs
1933 Industries got a lift on a second licensing agreement in the US
Buds & Duds: Pot stocks retreat as MedMen, HEXO earnings disappoint
Cannabis analytics company CB2 Insights gained on new agreement with VIVO Cannabis
Buds & Duds: Cannabis stocks grow to end the week; HEXO falls on downgrade, job cuts
Among those making gains was MedMen, which announced the opening of two retail locations in Florida
Buds & Duds: Cannabis stocks slide on Monday but Flower One shares rise on positive earnings
Also on the move were ICC International Cannabis, MedMen, Isodiol International Tilray and TILT
Buds & Duds: Cannabis stocks plummet, but Canntab bucks the trend as shares rise
Also on the move were Cannabis One, Golden Leaf, Isodiol, MedMen, Tilray and Green Growth Brands
Buds & Duds: Cannabis stocks flatten out; Namaste shares climb in anticipation of financial results
Also on the move were Canntab Therapeutics, Cannabis One, WeedMD, Tilray, Isodiol and MedMen
Buds & Duds: Cannabis stocks flatten out; ICC International Cannabis shares jump earlier on Wednesday on European distribution deal
Also on the move were Namaste, True Leaf, Aleafia, Tilray and MedMen
Multistate US cannabis operators positioned to capture sizable market cap, Roth says
The US cannabis industry’s eight biggest multistate operators, according to Roth, are Green Thumb, MedMen, Curaleaf, iAnthus Capital, Acreage Holdings, Cresco Labs, Harvest Health and Columbia Care
Buds & Duds: Aurora gains as Cowen impressed with Nelson Peltz investment
Also representing the cannabis sector well Friday were 1933 Industries, MedMen and HarvestOne
MedMen posts 40% jump in fiscal 2Q sales, thanks to California sales
Eight stores in California accounted for the bulk of sales in its latest quarter
Buds & Duds: Dual-listed cannabis stocks surge in Canada, but sink in the US ahead of farm bill decision
The farm bill may legalize hemp and hemp-derived CBD in the US on the federal level
MedMen taps Michael Kramer as new CFO
Kramer joins MedMen after serving as chief financial officer of Apple Retail
MedMen completes acquisition to open first store in Arizona
The cannabis company gained control of Monarch, a dispensary, cultivator and processor of medical cannabis
Buds & Duds: Canopy Growth, Tilray, Aurora Cannabis, MedMen and other notable names take a hit
Cannabis-focused life-science company CV Sciences was one of the few gainers on the North American Marijuana Index
MedMen’s fiscal 1Q sales rocket 1,094% as losses widen due to expansion
Strong results in California drove MedMen’s fiscal first-quarter revenue to $21.5 million from the $1.8 million in the first quarter of fiscal 2018
Buds & Duds: Rough start to the week for cannabis stocks as Canopy Growth and Aurora Cannabis shares dip
GW Pharmaceuticals was a top gainer on the North American Marijuana Index following positive data from its trial of Epidiolex, a treatment for a form of childhood epilepsy
Buds & Duds: Cannabis stocks tank in general; CannaRoyalty Corp, Liberty Health Sciences Inc drop
The North American Marijuana Index had a tough day, down 4.62%
Buds & Duds: Industrial Properties, ICC international Cannabis the only gainers in cannabis space
Innovative Industrial Properties, which leases medical cannabis facilities, was one of the only gainers on the North American Marijuana Index
Buds & Duds: Cannabis stocks were fired up after midterms, but end the week on a low note
Voters in Michigan, Missouri and Utah voted ‘yes’ on marijuana proposals in Tuesday’s election
MedMen’s latest acquisition to expand its presence in the Arizona cannabis market
The company has acquired control of Kannaboost Technology and CSI Solutions in a cash and stock deal valued at $33 million
CryptoCann™ Report: Bitcoin celebrates its 10th birthday; Francis Ford Coppola debuts cannabis line
Director Francis Ford Coppola plans to launch a line of cannabis in time for the holiday season
Buds & Duds: Cannabis stocks sink on Friday with most in the red; TerrAscend jumps
Cannabis stocks were down across the board on Friday, after a tough few weeks on the stock market since Canada legalized recreational cannabis on Oct. 17
Buds & Duds: Cannabis stocks ratchet it up on Thursday; Namaste Technologies soars
Cannabis stocks had a healthy day across both US and Canadian markets
MedMen sees net loss deepen in fiscal 4Q as expenses climb despite robust California sales
The company has been acquiring cannabis companies left and right and recently signed a letter of intent to acquire medical cannabis company PharmaCann in a $682 million deal
MedMen uplists to the OTCQX Best Market
The cannabis company hopes the uplisting increases its investor base as it continues expanding
Marijuana stocks continue to burn out as North American Marijuana Index falls double digits
Meanwhile, Aurora Cannabis shares were flat as the company awaits debut on the New York Stock Exchange
MedMen takes strategic stake in California cannabis flower brand Old Pal
The company isn’t disclosing the value of its investment, but the stake is set to widen MedMen's reach
Buds & Duds: Cannabis stocks plummet Monday after historic week
Cannabis stocks dropped like a stone across the board Monday, after a tough week last week
MedMen expands its reach into California’s cannabis market, scooping up a San Jose dispensary
The cannabis company has acquired Buddy’s Cannabis for an undisclosed amount
Buds & Duds: Cannabis stocks end a historic week on a low note
CannaRoyalty was one of the only gainers in the cannabis space as anticipation builds for its name change
Buds & Duds: Cannabis stocks end the week on a high note ahead of Canadian legalization
MPX Bioceutical shares jumped following the opening of its second dispensary in Maryland
CryptoCann™ Report: Ivy League schools investing in crypto funds; MedMen scoops up more cannabis licenses via PharmaCann acquisition
Yale, Harvard, Stanford, Dartmouth, MIT and UNC have reportedly invested in crypto funds
Cannabis stocks take a hit early Wednesday but perk up; Aphria rockets on news that it is reportedly in talks with tobacco powerhouse Altria to acquire equity stake
Aphria shares rocketed up after the Globe and Mail reported that Marlboro maker Altria Group is in talks for a stake in the Canadian cannabis producer
MedMen Enterprises signs deal for cannabis dispensary in California
The company has one of only two adult-use licenses in Emeryville, California
Nevada declares ‘MedMen Day’ as cannabis company continues its expansion
The company also brought in retail veteran Ben Cook as its new CFO
Cannabis stocks mix it up Friday: India Globalization Capital shares tank; CV Sciences skyrockets on no news
Cannabis stocks had a busy day on Friday, with significant roller-coaster activity, on the back of limited news. Shares of CV Sciences soared on the back of little to no news.
MedMen launches slew of cannabis products through deluxe Statemade brand
The new brand will carry its own line of pre-rolled joints, vaporizers, tinctures and cannabis flowers in markets like Arizona, Florida and New York City
Cannabis company MedMen Enterprises closes additional tranche on term loan facility
Proceeds from the loan will be used for acquisitions, capital expenditures and expenses
MedMen branches out into the Chicago market through its latest dispensary acquisition
The cannabis company will acquire Seven Point dispensary, located just outside of Chicago, for an undisclosed amount
MedMen cuts deal to expand into Arizona’s fast-growing medical marijuana market
The company cut a deal with WhiteStar Solutions to gain control of Monarch, an Arizona-based licensed medical-cannabis license holder, and other assets
Why America's cannabis companies are flocking to Canada to woo public investors
The Canadian Securities Exchange is becoming a wildly popular destination for US cannabis companies rejected by the NYSE and Nasdaq
CryptoCann™ Report: Yahoo Finance integrates Bitcoin trading; MedMen has ties to politicians in NY and LA
MedMen has reportedly donated US$140,000 to the governor of NY and added the former LA mayor to its board
CryptoCann™ Report: Yahoo Finance integrates Bitcoin trading; MedMen has ties to politicians in NY and LA
MedMen has donated US$140,000 to the governor of NY and added the former LA mayor to its board
Daily CryptoCann Report: The Federal Reserve launches a crypto index; LeBron James has a cannabis strain named after him
The Fed will use data from the Coinbase exchange to track Bitcoin, Bitcoin Cash, Ethereum and Litecoin
Daily CryptoCann Report: John McAfee swears off ICOs; Canada legalizes recreational cannabis
Sales of recreational cannabis are expected to begin in September but Canadian companies have been prepping for this moment for a while
Daily CryptoCann Report: Fidelity Investments may build a crypto exchange; MedMen acquires Florida cultivation facility
The investment giant is looking to hire developers capable of building a digital exchange
MedMen, US cannabis giant, set to become one of the largest Canadian-listed cannabis companies
The company, which began trading on the Canadian Securities Exchange today, has a fast-growing footprint that could redefine and modernize the Canadian cannabis retail space